Faeth Therapeutics (FTH) Other Working Capital Changes (2020 - 2026)

Faeth Therapeutics (FTH) has reported Other Working Capital Changes for 7 consecutive years, with -$430000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Working Capital Changes fell 14.06% year-over-year to -$430000.0; the trailing twelve-month figure through Jun 2026 stood at -$1.6 million (changed 0.19% YoY), and the FY2025 full-year result was -$1.6 million, changed 0.32% from the prior year.
• Other Working Capital Changes declined to -$430000.0 in Q2 2026 per FTH's latest filing, from -$407000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at -$271000.0 in Q1 2022 and bottomed at -$430000.0 in Q2 2026.
• Historically, Other Working Capital Changes has averaged -$359222.2 across 5 years, with a median of -$374500.0 in 2023.
• The widest YoY moves for Other Working Capital Changes: up 82.23% in 2022, down 113.6% in 2022.
• Over 5 years, Other Working Capital Changes stood at -$292000.0 in 2022, then decreased by 25.34% to -$366000.0 in 2023, then slipped by 13.93% to -$417000.0 in 2024, then increased by 4.32% to -$399000.0 in 2025, then slipped by 7.77% to -$430000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$430000.0, -$407000.0, and -$399000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.